What's on

  • April 20, 2017

    A study reveals the biological changes in breast cancer between the primary tumor and metastases

    A study published in the journal Cancer Research underscores the importance of the molecular characterization of the metastases in breast cancer. Researchers have described, for the first time, that the longer the time from the onset of the tumor to the development of metastasis is, the more aggressive this cancer becomes. They have also shown that between the initial tumor and the metastasis the subtype of breast cancer can change in up to 40% of cases. The work has been coordinated by Aleix Prat, Head of the Oncology Department of the Hospital Clínic, Head of the Translational Genomics team and directed therapies in solid tumors IDIBAPS team and Head of the VHIO Translational Genomics Group. The first author of the study is Juan Miguel Cejalvo, PhD student of the PhD4MD program in the group led by Aleix Prat at IDIBAPS and in the Growth Control and Cancer Metastasis group of the Institute for Research in Biomedicine (IRB Barcelona), led by the ICREA researcher Roger Gomis.

    Read the rest of this entry

  • April 5, 2017

    Elías Campo takes office as Director of IDIBAPS

    Yesterday, Tuesday, April 4th, Elías Campo took office as the new Director of IDIBAPS replacing Ramon Gomis, who has held the position since 2008. The election of the new director was made after an international call and an open selection process. Elías Campo is Research and Innovation Director of Hospital Clínic, Director of the Clinic Foundation and responsible for the group Molecular pathology of lymphoid neoplasms of IDIBAPS. He is also full professor in the Faculty of Medicine and Health Sciences at the University of Barcelona.

    Read the rest of this entry

  • April 4, 2017

    Ramon Gomis, Honorary Doctorate from the URV

    Last Friday, March 31, Ramon Gomis de Barbarà, director of IDIBAPS, was awarded an honorary doctorate from the Universitat Rovira i Virigili  (URV) for his contribution to biomedical research in the field of diabetes, obesity and nutrition.

    Read the rest of this entry

  • March 31, 2017

    IDIBAPS hosts the meeting of the HEP-CAR european project on hepatocarcinoma and co-morbidities

    On 13 March, IDIBAPS hosted the annual meeting of the European HEP-CAR consortium. The aim of the project is to identify the molecular mechanisms involved in the development of hepatocellular carcinoma (HCC) and their role in the different co-morbidities that induce the onset of this type of cancer: the infection by hepatitis B and C viruses, alcohol intake or obesity. Translational Reserarch in Hepatic Oncology IDIBAPS group, led by Dr. Josep M. Llovet, in collaboration with Dr. Roser Pinyol and 8 more researchers, participates in this research intiative.

    Read the rest of this entry

  • March 27, 2017

    The IDIBAPS participates in BIO-Europe Spring

    The Barcelona International Convention Center hosted from 20-22 March the BIO-Europe Spring conference. This is the most important partnering congress in Europe for the biotechnology and pharmaceutical industry. Attendees had 3 days to hold 30-minute private meetings with other international managers and business developers, from other institutions and companies around the world.

    Read the rest of this entry